An analysis of WHO's Temporary Recommendations on international travel and trade measures during Public Health Emergencies of International Concern.

Autor:	Worsnop CZ; School of Public Policy, University of Maryland, College Park, Maryland, USA cworsnop@umd.edu., Nass S; School of Public Policy, University of Maryland, College Park, Maryland, USA., Grépin KA; School of Public Health, University of Hong Kong Li Ka Shing Faculty of Medicine, Hong Kong, Hong Kong., Lee K; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.
Jazyk:	angličtina
Zdroj:	BMJ global health [BMJ Glob Health] 2023 Jul; Vol. 8 (7).
DOI:	10.1136/bmjgh-2023-012615
Abstrakt:	During Public Health Emergencies of International Concern (PHEICs), The International Health Regulations (IHR) require the WHO to issue Temporary Recommendations on the use of international travel and trade measures. During the COVID-19 pandemic, WHO's initial recommendation against 'any travel or trade restriction' has been questioned, and virtually all countries subsequently used international travel measures. WHO's Recommendations to States Parties also changed over the course of the pandemic. There is a need to understand how WHO's treatment of this issue compared with other PHEICs and why States Parties' actions diverged from WHO's initial Recommendations. This first analysis of WHO's Temporary Recommendations on international travel and trade measures during all seven PHEICs compares the guidance for clarity and consistency in several areas of substance and process. We find that lack of clarity and inconsistency in WHO guidance makes it difficult to interpret and relate back to IHR obligations. Based on this analysis, we offer recommendations to increase consistency and clarity of WHO's guidance on this issue during global health emergencies. Competing Interests: Competing interests: CZW was a member of a WHO guideline development group and technical consultation in 2019. KL was a member of two donor-funded reviews of WHO in 1995 and 1997. She was previously a codirector of the WHO Collaborating Centre on Global Change and Health, and has received WHO funding for research on globalisation and infectious diseases, global health governance, tobacco control and COVID-19. She is currently a member of an expert group and editorial board supporting the WHO Programme of Work on the Economic and Commercial Determinants of Health. (© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu